Morand S,Devanaboyina M,Staats H,Stanbery L,Nemunaitis J. Ovarian Cancer Personalized,Medicine Personalized .2021 .. Int J Mol Sci, 10(12) : 6532.
Stewart C,Ralyea C,Lockwood S. Ovarian C .2019 .Cancer: An Integrated Review. Semin Oncol Nurs, 02(2) : 151-156.
Lheureux S,Braunstein M,Oza AM .2019 .Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J Clin, 10(4) : 280-304.
Eisenhauer EA .2017 .Real-world evidence in the treatment of ovarian cancer. Ann Oncol, 10(suppl) : viii61-viii65.
Su X,Sun X,Kang Y,Dai Y. .2022 .Effects of carboplatin combined with paclitaxel-based intraperitoneal hyperthermic perfusion chemotherapy on serum levels of HE4 and DJ-1 in patients with advanced recurrent ovarian cancer. Pak J Med Sci, 10(4PartII) : 4736-877.
Lisio MA,Fu L,Goyeneche A,Gao ZH,Telleria C .2019 .High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints. Int J Mol Sci, 10(4) : 952.
Su X,Sun X,Wang Y,Kang Y,Dai Y. .2022 .Clinical effects of TP-based hyperthermic intraperitoneal chemotherapy (HIPEC) on CD133 and HE4 expression in advanced epithelial ovarian cancer. Pak J Med Sci, 10(6) : 5287-1513.
Lalchandani UR,Sahai V,Hersberger K,Francis IR,Wasnik AP .2018 .A Radiologist's Guide to Response Evaluation Criteria in Solid Tumors. Curr Probl Diagn Radiol, 07(6) : 576-585.
Vergote I,Harter P,Chiva L .2019 .Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer. Cancer, 10(Suppl24) : 4594-4597.
van Stein RM,Aalbers AGJ,Sonke GS .2021 .Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review. JAMA Oncol, 10(8) : 1231-1238.
Kim SI,Kim JH,Lee S,Cho H,van Driel WJ,Sonke GS .2022 .Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis. Gynecol Oncol, 10(3) : 547-556.
Gajarawala S,Pelkowski J,Dorian R,Stanton A,Dinh T. .2021 .Hyperthermic intraperitoneal chemotherapy for treating ovarian cancer. JAAPA, 0000735800(8) : 50-53.
Riggs MJ,Pandalai PK,Kim J,Dietrich CS .2020 .Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. Diagnostics (Basel), 10(1) : 43.
Tsuyoshi H,Inoue D,Kurokawa T,Yoshida Y. .2020 .Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer. J Obstet Gynaecol Res, 10(9) : 1661-1671.
Kim SI,Kim JW .2021 .Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer. ESMO Open, 10(3) : 100149.
van Driel WJ,Koole SN,Sikorska K,Schagen van Leeuwen JH,Schreuder HWR,Hermans RHM .2018 .. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med, 10(3) : 230-240.
Dong X,Men X,Zhang W .2014 .Advances in tumor markers of ovarian cancer for early diagnosis. Indian J Cancer, 10(Suppl3) : 154049-509X.
Lim MC,Chang SJ,Park B,Yoo HJ,Yoo CW,Nam BH .2022 .Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial. JAMA Surg, 10(5) : 374-383.
Anadon CM,Yu X,Hänggi K,Biswas S,Chaurio RA,Martin A .2022 .Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells. Cancer Cell, 03(5) : 545-557.
Hornburg M,Desbois M,Lu S,Guan Y,Lo AA,Kaufman S .2021 .Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell, 04(7) : 928-944.
Revaux A,Carbonnel M,Kanso F,Naoura I,Asmar J,Kadhel P .2020 .Hyperthermic intraperitoneal chemotherapy in ovarian cancer: an update. -0028, 10(3) : 10.